More importantly, after the establishment of obesity and T2DM, oral treatment with GABA significantly reduced the gain in body weight and improved glucose tolerance and insulin sensitivity in mice. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.